Home Newsfeeds FDA Grants Emergency Use Authorization For Thermo Fisher Scientific’s Monkeypox Test

FDA Grants Emergency Use Authorization For Thermo Fisher Scientific’s Monkeypox Test

-Reuters

byMichael Horton

December 14, 2022

1 minute read

-Reuters

‘Peter Thiel Confronted Mark Zuckerberg About Metaverse Focus Before Abrupt Board Resignation’ – New York Post

By Happy Mohamed

April 25, 11:26 AM

https://nypost.com/2023/04/25/peter-thiel-confronted-zuckerberg-about-metaverse-focus-before-board-resignation-report/ Billionaire tech investor Peter Thiel reportedly raised concern about Mark Zuckerberg’s

Credit Suisse Maintains Outperform on GCM Grosvenor, Lowers Price Target to $10.5

By Benzinga Newsdesk

February 21, 8:26 AM

Credit Suisse analyst Bill Katz maintains GCM Grosvenor (NASDAQ:GCMG) with a Outperform and lowers the price target from $11 to $10.5.

GCMG

Couple Takes 1,500-Mile EV Road Trip, But It Wasn’t Easy, This ‘Occupied Our Minds’

By Bibhu Pattnaik

February 15, 12:37 PM

A couple recently took their Hyundai Motor Company GDR (OTC: HYMTF) Kia EV6 electric car on a cross-country trip from Michigan to Florida, riding

HYMFT

Japanese Pharma Company Sponsors Australian Start Up In Development Of Non-Hallucinogenic Medicines

By Lara Goldstein

June 27, 5:00 PM

Australia biotech startup Psylo has inked a sponsored research agreement with global Japanese pharmaceutical company Daiichi Sankyo (OTCMKTS: DSNKY) toward advancing antidepressant psychiatric medicines.

DSNKY

FDA Grants Emergency Use Authorization For Thermo Fisher Scientific’s Monkeypox Test

Related Posts

‘Peter Thiel Confronted Mark Zuckerberg About Metaverse Focus Before Abrupt Board Resignation’ – New York Post

Credit Suisse Maintains Outperform on GCM Grosvenor, Lowers Price Target to $10.5

Couple Takes 1,500-Mile EV Road Trip, But It Wasn’t Easy, This ‘Occupied Our Minds’

Japanese Pharma Company Sponsors Australian Start Up In Development Of Non-Hallucinogenic Medicines